Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Trackit T4 EEG Amplifier

K-Number: K172271 · 2018-05-04

Decision Date2018-05-04
Product CodeGWQ
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

Trackit T4 EEG Amplifier is a medical device manufactured by Lifelines , Ltd.. It received FDA 510(k) clearance on 2018-05-04 under approval number K172271. The device is classified under product code GWQ. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Trackit T4 EEG Amplifier?

Trackit T4 EEG Amplifier is a medical device that received FDA 510(k) clearance on 2018-05-04. It is manufactured by Lifelines , Ltd.. The 510(k) number is K172271.

When was Trackit T4 EEG Amplifier approved by the FDA?

Trackit T4 EEG Amplifier received FDA 510(k) clearance on 2018-05-04, under approval number K172271.

What company makes Trackit T4 EEG Amplifier?

Trackit T4 EEG Amplifier is manufactured by Lifelines , Ltd..

What is the FDA product code for Trackit T4 EEG Amplifier?

The FDA product code for Trackit T4 EEG Amplifier is GWQ.

Related Devices (Code: GWQ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.